Dongni Hou

Dongni Hou

Auto-generated profile, based on publicly available information

Dongni Hou

Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2022 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
JSJun She
Jun She
DHDongni Hou
Dongni Hou
CCCuicui Chen
Cuicui Chen
JBJing Bi
Jing Bi
YSYuanlin Song
Yuanlin Song
Coronavirus disease 2019 (COVID‐19), the highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread worldwide with millions of cases and more than 5 million deaths to date. SARS‐CoV‐2 has caused serious damage all over the world with many countries experiencing the third or the fourth wave of the viral disease outbreaks, mainly due to the emergence of mutant variants. Those who unvaccinated remain most vulnerable to COVID‐19 and its variants. COVID‐19 vaccination, along with prevention strategies, is a critical measure to defense against the disease. COVID‐19 vaccination can reduce the spread of virus and help protect susceptible population. Although herd immunity might not be realized solely by vaccination, COVID‐19 vaccines have been proved to be effective in reducing the risk of severe disease, hospitalization, and even death. It is recommended that people get vaccinated as soon as they are eligible. This review summarizes the recent SARS‐CoV‐2 variants that brought challenges for vaccination and herd immunity and discusses promising management strategies.

13 May 2023 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Closed access
PDF file
TWTingting Wei
Tingting Wei
CCCuicui Chen
Cuicui Chen
YYYanjie Yang
Yanjie Yang
LLLi Li
Li Li
JWJian Wang
Jian Wang
DHDongni Hou
Dongni Hou

1 December 2023 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
YYYanping Yang
Yanping Yang
YSYuanlin Song
Yuanlin Song
DHDongni Hou
Dongni Hou
Obesity is a principle causative factor of various metabolic dysfunctions, chronic inflammation, and multi-organ impairment. The global epidemic of obesity has constituted the greatest threat to global health. Emerging evidence has associated obesity with an increased risk of severe infection and poor outcomes from coronavirus disease 2019 (COVID-19). During current COVID-19 pandemic, the interaction between COVID-19 and obesity has exaggerated the disease burden of obesity more than ever before. Thus, there is an urgent need for consideration of universal measures to reduce the risk of complications and severe illness from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in obesity population. In this review, we first summarized the clinical evidence on the effect of obesity on susceptibility, severity, and prognosis of COVID-19. Then we discussed and the underlying mechanisms, including respiratory pathophysiology of obesity, dysregulated inflammation, upregulated angiotensin-converting enzyme 2 (ACE2) expression, hyperglycemia, and adipokines. Finally, we proposed recommendations on how to reduce the spread and pandemic of SARS-CoV-2 infection by prevention and treatment of obesity.

9 August 2022 in Chronic Respiratory Disease
Verified
Journal Article
Open access
XWXiaoyue Wang
Xiaoyue Wang
HHHong He
Hong He
LXLiang Xu
Liang Xu
CCCuicui Chen
Cuicui Chen
JZJieqing Zhang
Jieqing Zhang
DHDongni Hou
Dongni Hou
Background: Active targeted case-finding is a cost-effective way to identify individuals with high-risk for early diagnosis and interventions of chronic obstructive pulmonary disease (COPD). A precise and practical COPD screening instrument is needed in health care settings. Methods: We created four statistical learning models to predict the risk of COPD using a multi-center randomized cross-sectional survey database ( n = 5281). The minimal set of predictors and the best statistical learning model in identifying individuals with airway obstruction were selected to construct a new case-finding questionnaire. We validated its performance in a prospective cohort ( n = 958) and compared it with three previously reported case-finding instruments. Results: A set of seven predictors was selected from 643 variables, including age, morning productive cough, wheeze, years of smoking cessation, gender, job, and pack-year of smoking. In four statistical learning models, generalized additive model model had the highest area under curve (AUC) value both on the developing cross-sectional data set (AUC = 0.813) and the prospective validation data set (AUC = 0.880). Our questionnaire outperforms the other three tools on the cross-sectional validation data set. Conclusions: We developed a COPD case-finding questionnaire, which is an efficient and cost-effective tool for identifying high-risk population of COPD.

30 October 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
WXWenyu Xing
Wenyu Xing
MLMiao Li
Miao Li
YLYiwen Liu
Yiwen Liu
XLXin Liu
Xin Liu
YLYifang Li
Yifang Li
Dean TaDean Ta
Dean Ta
Early prognostic prediction is crucial for determining appropriate clinical interventions. Previous single-omics models had limitations, such as high contingency and overlooking complex physical conditions. In this paper, we introduced multi-omics graph knowledge representation to predict in-hospital outcomes for pneumonia patients. This method utilizes CT imaging and three non-imaging omics information, and explores a knowledge graph for modeling multi-omics relations to enhance the overall information representation. For imaging omics, a multichannel pyramidal recursive MLP and Longformer-based 3D deep learning module was developed to extract depth features in lung window, while radiomics features were simultaneously extracted in both lung and mediastinal windows. Non-imaging omics involved the adoption of laboratory, microbial, and clinical indices to complement the patient's physical condition. Following feature screening, the similarity fusion network and graph convolutional network (GCN) were employed to determine omics similarity and provide prognostic prediction. The results of comparative experiments and generalization validation demonstrat that the proposed multi-omics GCN-based prediction model has good robustness and outperformed previous single-type omics, classical machine learning, and previous deep learning methods. Thus, the proposed multi-omics graph knowledge representation model enhances early prognostic prediction performance in pneumonia, facilitating a comprehensive assessment of disease severity and timely intervention for high-risk patients.

18 October 2022 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
DZDonghui Zhang
Donghui Zhang
SCShujing Chen
Shujing Chen
YWYing Wang
Ying Wang
DHDongni Hou
Dongni Hou
CCCuicui Chen
Cuicui Chen
YSYuanlin Song
Yuanlin Song
Introduction: Pulmonary infections are frequent in immunocompromised hosts (ICH), and microbial detection is difficult. As a new method, next‐generation sequencing (NGS) may offer a solution.Objectives: This study aimed to assess the impact of NGS‐assisted pathogenic detection on the diagnosis, treatment, and outcomes of ICH complicated by pulmonary infection and radiographic evidence of bilateral diffuse lesions.Methods: This study enrolled 356 patients with ICH complicated by pulmonary infection that were admitted to Zhongshan Hospital, Fudan University, from November 17, 2017, to November 23, 2018, including 102 and 254 in the NGS and non‐NGS groups, respectively. Clinical characteristics, detection time, rough positive rate, effective positive rate, impact on anti‐infective treatment plan, 30‐day/60‐day mortality, and in‐hospital mortality were compared.Results: NGS‐assisted pathogenic detection reduced detection time (28.2 h [interquartile range (IQR) 25.9–29.83 h] vs. 50.50 h [IQR 47.90–90.91 h], P < 0.001), increased positive rate, rate of mixed infection detected, effective positive rate, and proportion of antibiotic treatment modification (45.28% vs. 89.22%, 4.72% vs. 51.96%, 21.65% vs. 64.71%, 16.54% vs. 46.08%, P < 0.001). The NGS group had a significantly lower 60‐day mortality rate (18.63% vs. 33.07%, P = 0.007). The difference in the Kaplan–Meier survival curve was significant (P = 0.029). After multivariate logistic regression, NGS‐assisted pathogenic detection remained a significant predictor of survival (OR 0.189, confidence interval [CI], 0.068–0.526).Conclusion: NGS‐assisted pathogenic detection may improve detection efficiency and is associated with better clinical outcomes in these patients.